Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,727 | -3,148 | -20,293 | -13,198 | -4,686 |
| Depreciation Amortization | 16,694 | 7,915 | 30,098 | 20,859 | 13,819 |
| Income taxes - deferred | N/A | N/A | 4,032 | N/A | N/A |
| Accounts receivable | 2,064 | -2,242 | -30,473 | -13,660 | -8,898 |
| Accounts payable and accrued liabilities | -364 | -622 | -1,385 | -9,530 | -796 |
| Other Working Capital | -10,497 | -649 | -20,596 | -14,661 | -16,568 |
| Other Operating Activity | 9,156 | 5,071 | 58,343 | 44,438 | 27,443 |
| Operating Cash Flow | $11,326 | $6,325 | $19,726 | $14,248 | $10,314 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 34,019 | 34,019 | 34,019 |
| PPE Investments | -3,387 | -2,473 | -4,066 | -2,749 | -1,464 |
| Net Acquisitions | 151 | N/A | -190,888 | -142,592 | -147,436 |
| Purchase Sale Intangibles | -298 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -298 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,534 | $-2,473 | $-160,935 | $-111,322 | $-114,881 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 60,000 | 10,000 |
| Debt Issued | N/A | N/A | 60,000 | N/A | N/A |
| Debt Repayment | -35,000 | -25,000 | -45,000 | -45,000 | -40,000 |
| Common Stock Issued | 5,092 | 577 | 3,466 | 2,247 | 2,073 |
| Common Stock Repurchased | -5,630 | -4,736 | -2,268 | -2,268 | -2,268 |
| Other Financing Activity | -473 | -166 | -10,372 | -6,985 | -5,674 |
| Financing Cash Flow | $-36,011 | $-29,325 | $5,826 | $7,994 | $-35,869 |
| Exchange Rate Effect | -5,823 | 994 | 10,782 | 7,934 | 7,188 |
| Beginning Cash Position | 88,950 | 88,950 | 213,551 | 213,551 | 213,551 |
| End Cash Position | 54,908 | 64,471 | 88,950 | 132,405 | 80,303 |
| Net Cash Flow | $-34,042 | $-24,479 | $-124,601 | $-81,146 | $-133,248 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,326 | 6,325 | 19,726 | 14,248 | 10,314 |
| Capital Expenditure | -3,387 | -2,473 | -4,066 | -2,749 | -1,464 |
| Free Cash Flow | 7,939 | 3,852 | 15,660 | 11,499 | 8,850 |